ZA200702427B - Compositions monovalent for CD40L binding and methods of use - Google Patents

Compositions monovalent for CD40L binding and methods of use

Info

Publication number
ZA200702427B
ZA200702427B ZA200702427A ZA200702427A ZA200702427B ZA 200702427 B ZA200702427 B ZA 200702427B ZA 200702427 A ZA200702427 A ZA 200702427A ZA 200702427 A ZA200702427 A ZA 200702427A ZA 200702427 B ZA200702427 B ZA 200702427B
Authority
ZA
South Africa
Prior art keywords
methods
cd40l binding
monovalent
compositions
compositions monovalent
Prior art date
Application number
ZA200702427A
Inventor
Grant Steven
Liu Haiqun
Moulder Kevin
Original Assignee
Domantis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Domantis Ltd filed Critical Domantis Ltd
Publication of ZA200702427B publication Critical patent/ZA200702427B/en

Links

ZA200702427A 2004-09-17 2005-09-16 Compositions monovalent for CD40L binding and methods of use ZA200702427B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61081904P 2004-09-17 2004-09-17

Publications (1)

Publication Number Publication Date
ZA200702427B true ZA200702427B (en) 2008-12-31

Family

ID=38866634

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200702427A ZA200702427B (en) 2004-09-17 2005-09-16 Compositions monovalent for CD40L binding and methods of use

Country Status (3)

Country Link
CN (1) CN101061140B (en)
UA (1) UA94213C2 (en)
ZA (1) ZA200702427B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20110385A1 (en) * 2008-07-18 2011-06-22 Bristol Myers Squibb Co DOMAIN ANTIBODY (DAB) THAT JOINS CD28 AND DOES NOT CROSS-REACT WITH CTLA4
AU2012245309C1 (en) 2011-04-21 2016-07-21 Bristol-Myers Squibb Company Antibody polypeptides that antagonize CD40
US9499612B2 (en) * 2011-07-27 2016-11-22 Glaxo Group Limited Antigen binding constructs
KR101637915B1 (en) * 2011-10-13 2016-07-11 브리스톨-마이어스 스큅 컴퍼니 Antibody polypeptides that antagonize cd40l
ITTO20130012A1 (en) * 2013-01-09 2014-07-10 Metheresis Translational Res S A NEW ANTICORPAL FRAGMENTS, RELATED COMPOSITIONS AND USES
JP7325166B2 (en) * 2013-12-20 2023-08-14 ジェネンテック， インコーポレイテッド Bispecific antibody
CA2932547C (en) * 2014-01-06 2023-05-23 F. Hoffmann-La Roche Ag Monovalent blood brain barrier shuttle modules
US10435475B2 (en) 2014-03-07 2019-10-08 Bristol-Myers Squibb Company Method of using antibody polypeptides that antagonize CD40 to treat IBD
CA2969867C (en) * 2014-12-22 2022-01-25 Systimmune, Inc. Bispecific tetravalent antibodies and methods of making and using thereof
EP3292143B1 (en) * 2015-05-04 2019-08-21 Apogenix AG Single-chain cd40-receptor agonist proteins
MY192668A (en) 2015-10-02 2022-08-30 Hoffmann La Roche Bispecific anti-human cd20/human transferrin receptor antibodies and methods of use
CN114149508B (en) * 2021-11-25 2023-04-28 苏州普乐康医药科技有限公司 Fusion protein combined with CD40L and application thereof

Also Published As

Publication number Publication date
UA94213C2 (en) 2011-04-26
CN101061140B (en) 2015-07-01
CN101061140A (en) 2007-10-24

Similar Documents

Publication Publication Date Title
IL181724A0 (en) Compositions monovalent for cd40l binding and methods of use
ZA200702427B (en) Compositions monovalent for CD40L binding and methods of use
EP1812031A4 (en) Compositions and methods for modification of biomolecules
GB2423928B (en) Methods and compositions for treating pain
EP1971367A4 (en) Methods and compositions for needleless delivery of binding partners
EP1718282A4 (en) Methods and compositions for imaging
EP1744825A4 (en) Colloidal compositions and methods of preparing same
EP1765367A4 (en) Phospholipid compositions and methods for their preparation and use
PT2101766T (en) Compositions and methods of using (r)-pramipexole
EP1718331A4 (en) Methods and compositions for dosing of allergens
IL179241A0 (en) Compositions and methods for bone formation and remodeling
EP1765873A4 (en) Methods and compositions using cd3 agonists
EP2057284A4 (en) Compositions and methods for the modulation of jnk proteins
EP1814575A4 (en) Methods and compositions for treating conditions
IL182943A0 (en) Ovr110 antibody compositions and methods of use
IL180907A0 (en) Risedronate compositions and their methods of use
EP1735456A4 (en) Polymeric compositions and related methods of use
ZA200705196B (en) Compositions and methods for improving kidney function
EP1763358A4 (en) Appetite-suppressing compositions and methods
PL2101766T3 (en) Compositions and methods of using (r)-pramipexole
EP1762216A4 (en) Composition for cosmetic preparation and cosmetic preparation
EP1773386A4 (en) Vaccine compositions and methods
HK1109576A1 (en) Aequorin-containing compositions and methods of using same
EP2099416A4 (en) Anti-calculus dental composition and methods for using same
EP1811846A4 (en) Methods for making and using synergistic multifunctional compositions